PFIZER SATELLITE symposium speakers
Shakeel Mowlaboccus
Biography
Dr Shakeel (Shaxx) Mowlaboccus is an early-career researcher in the field of infectious diseases and antimicrobial resistance with over ten years of experience in microbiology, large-scale whole genome sequencing, bioinformatics analyses, and molecular cloning. He completed his PhD at the University of Western Australia in 2018. He specialises in understanding the molecular epidemiology and evolution of bacterial pathogens through state-of-the-art genomics. To date, Dr Mowlaboccus has sequenced and analysed more than 7,000 bacterial genomes. His research focuses on understanding the molecular mechanisms and the evolution of antimicrobial resistance in bacterial pathogens of public health concern including methicillin-resistant S. aureus, Enterococcus faecium, and Neisseria gonorrhoeae. He is the curator of MLST profiles of Enterococcus faecium and Enterococcus faecalis. Dr Mowlaboccus is the current International Young Ambassador representing Australia at the American Society for Microbiology and the Chair-elect of the Western Australia branch of the Australian Society for Microbiology.
Dr Shakeel (Shaxx) Mowlaboccus is an early-career researcher in the field of infectious diseases and antimicrobial resistance with over ten years of experience in microbiology, large-scale whole genome sequencing, bioinformatics analyses, and molecular cloning. He completed his PhD at the University of Western Australia in 2018. He specialises in understanding the molecular epidemiology and evolution of bacterial pathogens through state-of-the-art genomics. To date, Dr Mowlaboccus has sequenced and analysed more than 7,000 bacterial genomes. His research focuses on understanding the molecular mechanisms and the evolution of antimicrobial resistance in bacterial pathogens of public health concern including methicillin-resistant S. aureus, Enterococcus faecium, and Neisseria gonorrhoeae. He is the curator of MLST profiles of Enterococcus faecium and Enterococcus faecalis. Dr Mowlaboccus is the current International Young Ambassador representing Australia at the American Society for Microbiology and the Chair-elect of the Western Australia branch of the Australian Society for Microbiology.
An overview of the epidemiology and resistance patterns of serious CA-MRSA infections in Australia.
Monday, August 19, 2024
12:00 PM - 12:20 PM
BelleVue Ballroom 2
Symposium
Asha Bowen
Biography
Professor Asha Bowen is a clinician scientist working across the Perth Children’s Hospital as a paediatric infectious disease specialist and the Telethon Kids Institute as Head of the Healthy Skin and ARF Prevention Team. Asha and her team recently launched the second edition of the National Healthy Skin Guidelines to guide clinicians in the recognition and evidence-based treatment of skin infections. Asha is the lead paediatrician on the SNAP Trial and conceptualised the inclusion of children alongside adults in this world first trial to improve outcomes for Staph aureus bloodstream infection, across the life course.
The clinical impact of serious CA-MRSA infections in Australia, with a focus on remote and rural communities.
Monday, August 19, 2024
12:20 PM - 12:40 PM
BelleVue Ballroom 2
Symposium
Sebastian van Hal
Biography
Sebastian van Hal obtained his medical degree from The University of Cape Town, South Africa, in 1995. After working extensively in Africa and Europe, he moved to Australia and completed his training in Infectious Diseases and Microbiology. He is a Staff Specialist at the Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital and a Conjoint Associate Professor at the School of Medicine, University of Western Sydney. He has published over a 100 peer reviewed papers focusing on the consequences and mechanisms of antibiotic resistance in Staphylococcus aureus and Enterococcus faecium. In 2014 he spent time at the Oxford Genomics Centre acquiring the skills required for translation of microbial genomics into hospital epidemiology and is responsible for this evolving service at RPAH. He is also an active member of AGAR (Australian Group of Antimicrobial Resistance) and AURA (Antimicrobial Use and Resistance in Australia) and ANZMIG (Australian New Zealand Mycology Interest Group) which have led to several prominent publications including the development of the Antifungal Consensus guidelines.
Current therapeutic options for the treatment of serious CA-MRSA infections in the Australian context.
Monday, August 19, 2024
12:40 PM - 1:00 PM
BelleVue Ballroom 2
Symposium
David Grolman
Chair
Monday, August 19, 2024
12:00 PM - 1:30 PM
BelleVue Ballroom 2
Symposium